| References |
|
|
Anand V,
Barral DC,
Zeng Y et al.
(2003)
Gene therapy for choroideremia: in vitro rescue mediated by recombinant adenovirus.
Vision Research
43(8):
919–926.
|
|
|
Bainbridge JW,
Smith AJ,
Barker SS et al.
(2008)
Effect of gene therapy on visual function in Leber's congenital amaurosis.
The New England Journal of Medicine
358(21):
2231–2239.
|
|
|
Beaufrere L,
Claustres M and
Tuffery S
(1999)
No missense mutation in choroideremia patients analyzed to date.
Ophthalmic Genetics
20(2):
89–93.
|
|
|
Beaufrere L,
Tuffery S,
Hamel C et al.
(1997)
The protein truncation test (PTT) as a method of detection for choroideremia mutations.
Experimental Eye Research
65(6):
849–854.
|
|
|
Bett AJ,
Prevec L and
Graham FL
(1993)
Packaging capacity and stability of human adenovirus type 5 vectors.
Journal of Virology
67(10):
5911–5921.
|
|
|
van Bokhoven H,
van den Hurk JA,
Bogerd L et al.
(1994)
Cloning and characterization of the human choroideremia gene.
Human Molecular Genetics
3(7):
1041–1046.
|
|
|
Bonilha VL,
Trzupek KM,
Li Y et al.
(2008)
Choroideremia: analysis of the retina from a female symptomatic carrier.
Ophthalmic Genetics
29(3):
99–110.
|
|
|
Cremers FP,
Armstrong SA,
Seabra MC,
Brown MS and
Goldstein JL
(1994)
REP-2, a Rab escort protein encoded by the choroideremia-like gene.
The Journal of Biological Chemistry
269(3):
2111–2117.
|
|
|
Cremers FP,
Molloy CM,
van de Pol DJ et al.
(1992)
An autosomal homologue of the choroideremia gene colocalizes with the Usher syndrome type II locus on the distal part of chromosome 1q.
Human Molecular Genetics
1(2):
71–75.
|
|
|
Cremers FP,
van de Pol DJ,
Wieringa B et al.
(1989)
Chromosomal jumping from the DXS165 locus allows molecular characterization of four microdeletions and a de novo chromosome X/13 translocation associated with choroideremia.
Proceedings of the National Academy of Sciences of the USA
86(19):
7510–7514.
|
|
|
Chen MS,
Chang CC,
Ho TC et al.
(2010)
Blood-aqueous barrier function in a patient with choroideremia.
Journal of the Formosan Medical Association=Taiwan Yi Zhi
109(2):
167–171.
|
|
|
Dastgheib K and
Green WR
(1994)
Granulomatous reaction to Bruch's membrane in age-related macular degeneration.
Archives of Ophthalmology
112(6):
813–818.
|
|
|
Donnelly P,
Menet H,
Fouanon C et al.
(1994)
Missense mutation in the choroideremia gene.
Human Molecular Genetics
3(6):
1017.
|
|
|
Esposito G,
De Falco F,
Tinto N et al.
(2011)
Comprehensive mutation analysis (20 families) of the choroideremia gene reveals a missense variant that prevents the binding of REP1 with Rab geranylgeranyl transferase.
Human Mutation
32(12):
1460–1469.
|
|
|
Flannery JG,
Bird AC,
Farber DB,
Weleber RG and
Bok D
(1990)
A histopathologic study of a choroideremia carrier.
Investigative Ophthalmology and Visual Science
31(2):
229–236.
|
|
|
Goldmann T,
Overlack N,
Wolfrum U and
Nagel-Wolfrum K
(2011)
PTC124-mediated translational readthrough of a nonsense mutation causing Usher syndrome type 1C.
Human Gene Therapy
22(5):
537–547.
|
|
|
Gordiyenko NV,
Fariss RN,
Zhi C and
MacDonald IM
(2010)
Silencing of the CHM gene alters phagocytic and secretory pathways in the retinal pigment epithelium.
Investigative Ophthalmology and Visual Science
51(2):
1143–1150.
|
|
|
Grover S,
Alexander KR,
Choi DM and
Fishman GA
(1998)
Intraocular light scatter in patients with choroideremia.
Ophthalmology
105(9):
1641–1645.
|
|
|
Guerin K,
Gregory-Evans CY,
Hodges MD et al.
(2008)
Systemic aminoglycoside treatment in rodent models of retinitis pigmentosa.
Experimental Eye Research
87(3):
197–207.
|
|
|
Hainrichson M,
Nudelman I and
Baasov T
(2008)
Designer aminoglycosides: the race to develop improved antibiotics and compounds for the treatment of human genetic diseases.
Organic and Biomolecular Chemistry
6(2):
227–239.
|
|
|
Hildebrand MS,
de Silva MG,
Tan TY et al.
(2007)
Molecular characterization of a novel X-linked syndrome involving developmental delay and deafness.
American Journal of Medical Genetics. Part A
143A(21):
2564–2575.
|
|
|
van den Hurk JA,
Schwartz M,
van Bokhoven H et al.
(1997)
Molecular basis of choroideremia (CHM): mutations involving the Rab escort protein-1 (REP-1) gene.
Human Mutation
9(2):
110–117.
|
|
|
Jacobson SG,
Cideciyan AV,
Ratnakaram R et al.
(2012)
Gene therapy for leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years.
Archives of Ophthalmology
130(1):
9–24.
|
|
|
Jacobson SG,
Cideciyan AV,
Sumaroka A et al.
(2006)
Remodeling of the human retina in choroideremia: rab escort protein 1 (REP-1) mutations.
Investigative Ophthalmology and Visual Science
47(9):
4113–4120.
|
|
|
Jung Y,
Huh J,
Kim D et al.
(2011)
Quantitative analysis of transcript variants of CHM gene containing LTR12C element in humans.
Gene
489(1):
1–5.
|
|
|
Kozlowski P,
Jasinska AJ and
Kwiatkowski DJ
(2008)
New applications and developments in the use of multiplex ligation-dependent probe amplification.
Electrophoresis
29(23):
4627–4636.
|
|
|
Lazow MA,
Hood DC,
Ramachandran R et al.
(2011)
Transition zones between healthy and diseased retina in choroideremia (CHM) and Stargardt disease (STGD) as compared to retinitis pigmentosa (RP).
Investigative Ophthalmology and Visual Science
52(13):
9581–9590.
|
|
|
Lebherz C,
Maguire A,
Tang W,
Bennett J and
Wilson JM
(2008)
Novel AAV serotypes for improved ocular gene transfer.
The Journal of Gene Medicine
10(4):
375–382.
|
|
|
Lehrman S
(1999)
Virus treatment questioned after gene therapy death.
Nature
401(6753):
517–518.
|
|
|
Leung KF,
Baron R and
Seabra MC
(2006)
Thematic review series: lipid posttranslational modifications. geranylgeranylation of Rab GTPases.
Journal of Lipid Research
47(3):
467–475.
|
|
|
Lorda-Sanchez IJ,
Ibanez AJ,
Sanz RJ et al.
(2000)
Choroideremia, sensorineural deafness, and primary ovarian failure in a woman with a balanced X-4 translocation.
Ophthalmic Genetics
21(3):
185–189.
|
|
|
Lyon MF
(1961)
Gene action in the X-chromosome of the mouse (Mus musculus L.).
Nature
190:
372–373.
|
|
|
MacDonald IM,
Mah DY,
Ho YK,
Lewis RA and
Seabra MC
(1998)
A practical diagnostic test for choroideremia.
Ophthalmology
105(9):
1637–1640.
|
|
|
MacDonald IM,
Russell L and
Chan C
(2009)
Choroideremia: new findings from ocular pathology and review of recent literature.
Survey of Ophthalmology
54(3):
401–407.
|
|
|
MacDonald IM,
Sereda C,
McTaggart K and
Mah D
(2004)
Choroideremia gene testing.
Expert Review of Molecular Diagnostics
4(4):
478–484.
|
|
|
book
MacDonald IM,
Smaoui N and
Seabra MC
(1993)
"Choroideremia" In:
Pagon RA,
Bird TD,
Dolan CR et al. (eds)
GeneReviews.
Seattle (WA): University of Washington, Seattle.
|
|
|
Maguire AM,
Simonelli F,
Pierce EA et al.
(2008)
Safety and efficacy of gene transfer for Leber's congenital amaurosis.
New England Journal of Medicine
358(21):
2240–2248.
|
|
|
Majid MA,
Horsborough B and
Gray RH
(1998)
Unusual macular findings in a known choroideremia carrier.
Eye (London, England)
12(Pt 4):
740–741.
|
|
|
Mauthner H
(1871)
Ein fall von chorioideremia.
Naturwissenschaftlich Medezinischer Verein
2:
191.
|
|
|
Merry DE,
Lesko JG,
Sosnoski DM et al.
(1989)
Choroideremia and deafness with stapes fixation: a contiguous gene deletion syndrome in Xq21.
American Journal of Human Genetics
45(4):
530–540.
|
|
|
Moosajee M,
Gregory-Evans K,
Ellis CD,
Seabra MC and
Gregory-Evans CY
(2008)
Translational bypass of nonsense mutations in zebrafish rep1, pax2.1 and lamb1 highlights a viable therapeutic option for untreatable genetic eye disease.
Human Molecular Genetics
17(24):
3987–4000.
|
|
|
Moosajee M,
Tulloch M,
Baron RA et al.
(2009)
Single choroideremia gene in nonmammalian vertebrates explains early embryonic lethality of the zebrafish model of choroideremia.
Investigative Ophthalmology and Visual Science
50(6):
3009–3016.
|
|
|
Mukkamala K,
Gentile RC,
Willner J and
Tsang S
(2010)
Choroideremia in a woman with ectodermal dysplasia and complex translocations involving chromosomes X, 1, and 3.
Ophthalmic Genetics
31(4):
178–182.
|
|
|
Mura M,
Sereda C,
Jablonski MM,
MacDonald IM and
Iannaccone A
(2007)
Clinical and functional findings in choroideremia due to complete deletion of the CHM gene.
Archives of Ophthalmology
125(8):
1107–1113.
|
|
|
Noble KG,
Carr RE and
Siegel IM
(1977)
Fluorescein angiography of the hereditary choroidal dystrophies.
The British Journal of Ophthalmology
61(1):
43–53.
|
|
|
Poloschek CM,
Kloeckener-Gruissem B,
Hansen LL,
Bach M and
Berger W
(2008)
Syndromic choroideremia: sublocalization of phenotypes associated with Martin-Probst deafness mental retardation syndrome.
Investigative Ophthalmology and Visual Science
49(9):
4096–4104.
|
|
|
Preising MN,
Wegscheider E,
Friedburg C et al.
(2009)
Fundus autofluorescence in carriers of choroideremia and correlation with electrophysiologic and psychophysical data.
Ophthalmology
116(6):
1201–1209, e1–e2.
|
|
|
Renner AB,
Kellner U,
Cropp E et al.
(2006)
Choroideremia: variability of clinical and electrophysiological characteristics and first report of a negative electroretinogram.
Ophthalmology
113(11):
2066–2073, e2.
|
|
|
Rizzolio F,
Sala C,
Alboresi S et al.
(2007)
Epigenetic control of the critical region for premature ovarian failure on autosomal genes translocated to the X chromosome: a hypothesis.
Human Genetics
121(3-4):
441–450.
|
|
|
Robert L,
Senechal A,
Bocquet B et al.
(2011)
Screening for a canine model of choroideremia exclusively identifies nonpathogenic CHM variants.
Ophthalmic Research
45(3):
155–163.
|
|
|
Roberts MF,
Fishman GA,
Roberts DK et al.
(2002)
Retrospective, longitudinal, and cross sectional study of visual acuity impairment in choroideraemia.
British Journal of Ophthalmology
86(6):
658–662.
|
|
|
Rosenberg T,
Schwartz M,
Niebuhr E et al.
(1986)
Choroideremia in interstitial deletion of the X chromosome.
Ophthalmic Paediatrics and Genetics
7(3):
205–210.
|
|
|
Rudolph G,
Preising M,
Kalpadakis P et al.
(2003)
Phenotypic variability in three carriers from a family with choroideremia and a frameshift mutation 1388delCCinsG in the REP-1 gene.
Ophthalmic Genetics
24(4):
203–214.
|
|
|
Seabra MC,
Ho YK and
Anant JS
(1995)
Deficient geranylgeranylation of Ram/Rab27 in choroideremia.
Journal of Biological Chemistry
270(41):
24420–24427.
|
|
|
Seabra MC,
Mules EH and
Hume AN
(2002)
Rab GTPases, intracellular traffic and disease.
Trends in Molecular Medicine
8(1):
23–30.
|
|
|
Sergeev YV,
Smaoui N,
Sui R et al.
(2009)
The functional effect of pathogenic mutations in Rab escort protein 1.
Mutation Research
665(1–2):
44–50.
|
|
|
Shi W,
van den Hurk JA,
Alamo-Bethencourt V et al.
(2004)
Choroideremia gene product affects trophoblast development and vascularization in mouse extra-embryonic tissues.
Developmental Biology
272(1):
53–65.
|
|
|
Sin HS,
Huh JW,
Kim DS et al.
(2006)
Transcriptional control of the HERV-H LTR element of the GSDML gene in human tissues and cancer cells.
Archives of Virology
151(10):
1985–1994.
|
|
|
Strauss O
(2005)
The retinal pigment epithelium in visual function.
Physiological Reviews
85(3):
845–881.
|
|
|
Strunnikova N,
Zein WM,
Silvin C and
MacDonald IM
(2012)
Serum biomarkers and trafficking defects in peripheral tissues reflect the severity of retinopathy in three brothers affected by choroideremia.
Advances in Experimental Medicine and Biology
723:
381–387.
|
|
|
Strunnikova NV,
Barb J,
Sergeev YV et al.
(2009)
Loss-of-function mutations in Rab escort protein 1 (REP-1) affect intracellular transport in fibroblasts and monocytes of choroideremia patients.
PloS One
4(12):
e8402.
|
|
|
Surace EM and
Auricchio A
(2008)
Versatility of AAV vectors for retinal gene transfer.
Vision Research
48(3):
353–359.
|
|
|
Syed N,
Smith JE,
John SK et al.
(2001)
Evaluation of retinal photoreceptors and pigment epithelium in a female carrier of choroideremia.
Ophthalmology
108(4):
711–720.
|
|
|
Tabor A,
Andersen O,
Lundsteen C,
Niebuhr E and
Sardemann H
(1983)
Interstitial deletion in the ‘critical region’ of the long arm of the X chromosome in a mentally retarded boy and his normal mother.
Human Genetics
64(2):
196–199.
|
|
|
Tanaka D,
Kameyama K,
Okamoto H and
Doi M
(2008)
Caenorhabditis elegans Rab escort protein (REP-1) differently regulates each Rab protein function and localization in a tissue-dependent manner.
Genes to Cells: Devoted to Molecular and Cellular Mechanisms
13(11):
1141–1157.
|
|
|
Tolmachova T,
Anders R,
Abrink M et al.
(2006)
Independent degeneration of photoreceptors and retinal pigment epithelium in conditional knockout mouse models of choroideremia.
The Journal of Clinical Investigation
116(2):
386–394.
|
|
|
Tolmachova T,
Tolmachov OE,
Wavre-Shapton ST et al.
(2012)
CHM/REP1 cDNA delivery by lentiviral vectors provides functional expression of the transgene in the retinal pigment epithelium of choroideremia mice.
The Journal of Gene Medicine
14(3):
158–168.
|
|
|
Tolmachova T,
Wavre-Shapton ST,
Barnard AR et al.
(2010)
Retinal pigment epithelium defects accelerate photoreceptor degeneration in cell type-specific knockout mouse models of choroideremia.
Investigative Ophthalmology and Visual Science
51(10):
4913–4920.
|
|
|
Vajaranant TS,
Fishman GA,
Szlyk JP et al.
(2008)
Detection of mosaic retinal dysfunction in choroideremia carriers electroretinographic and psychophysical testing.
Ophthalmology
115(4):
723–729.
|
|
|
Welch EM,
Barton ER,
Zhuo J et al.
(2007)
PTC124 targets genetic disorders caused by nonsense mutations.
Nature
447(7140):
87–91.
|
|
|
book
Weleber RG,
Francis PJ and
Trzupek KM
(1993)
"Leber congenital amaurosis". In:
Pagon RA,
Bird TD,
Dolan CR et al. (eds)
GeneReviews.
Seattle (WA): University of Washington, Seattle.
|
|
|
Wilschanski M,
Miller LL,
Shoseyov D et al.
(2011)
Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis.
European Respiratory Journal
38(1):
59–69.
|
| Further Reading |
|
|
book
MacDonald IM and
Seabra MC
(2011)
"Choroideremia". In:
Traboulsi EI (ed.)
Genetic Diseases of the Eye,
2nd edn., pp.
484–490.
New York: Oxford University Press, Inc.
|
|
|
Stone EM
(2003)
Finding and interpreting genetic variations that are important to ophthalmologists.
Transactions of the American Ophthalmological Society
101:
437–484.
|
